 Novus Therapeutics, Inc. NVUS, a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat ENT, today announced that the company will participate in two upcoming investor conferences in New York City. Novus Therapeutics, Inc. Novus is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat ENT. The Company has two platform technologies, each with the potential to be developed for multiple indications. 